CVT Inhibits the Intralipid Rescue of Bupivacaine-Induced Cardiotoxicity in a Dose-Dependant Manner  by Partownavid, Parisa et al.
296a Monday, March 7, 2011with DPN and PPT. DPN treatment improved LVDP from 94.6855.14 in HF
to 119.355.5 and RPP from 39749.954527.03 in HF to 62794.0455534.62.
PPT treatment had no effect on LV mechanical performance as both LVDP and
RPP were not significantly different from their corresponding values in HF.
The relaxation and contraction defects of HF mice (dP/dtmax and dP/dtmin)
were also partially restored by DPN but not by PPT. Our data strongly support
the view that ERb is the main player in rescuing advanced HF by E2.
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Phosphorylation of GSK-3b is Required for Intralipid to Protect the Heart
Against Ischemia/Reperfusion Injury
Siamak Rahman, Jingyuan Li, Jean C. Bopassa, Andrea Iorga,
Parisa Partownavid, Mansoureh Eghbali.
Recently we found that administration of Intralipid (ILP) during reperfusion
significantly improves post-ischemic cardiac function and reduces the myocar-
dial infarct size by ~70% , both in the isolated mouse heart and in-vivo rat heart.
Here we investigated whether ILP-induced cardioprotection is mediated
through the inhibition of GSK-3b. Wild type (WT) C57BL/6 male mice and
GSK-3b Knockin (KI) were used. The isolated hearts were subjected to 20
min of global normothermic ischemia followed by reperfusion with 1% ILP
(40 min for heart function and infarct size and 10 min for calcium retention
capacity (CRC) experiments). The left ventricular (LV) systolic pressure, LV
end-diastolic pressure (LVDP), heart rate, maximum velocity of contraction
(dP/dt max) and maximum velocity of relaxation (dP/dt min) were recorded.
Myocardial necrosis was assessed using TTC staining. Mitochondria were iso-
lated to measure CRC by calculating the number of pulses required to trigger
the opening of the mitochondrial transition permeability pore as a result of cal-
cium overload. Before ischemia, the baseline RPP, LVDP, dP/dtmax and dP/
dtmin in GSK-3b KI mice were similar to WT. However, the functional recov-
ery during reperfusion was very poor in GSK-3b KI mice. At the end of 40 min
of reperfusion, the RPP was 19905499 in GSK-3b KI mice vs.
1540551011mmHg*beats/min in WT, the LV dP/dtmax was 239.7517.8 in
GSK-3b KI vs. 27035145 mmHg/s in WT and the LV dP/dtmin was
219514 in GSK-3b KI vs. 1683566 mmHg/s in WT. The infarct size was sig-
nificantly larger compared to WT (45.3510.3 vs. 16.752.33% in WT,
P<0.001). Postischemic administration of ILP in GSK-3b KI mice demon-
strated lower CRC than WT (1.350.1 vs. 2.750.06 mM/mg-mitochondrial
protein in WT). In conclusions, these data demonstrate that phosphoryltaion
of GSK-3b is required for the cardioprotective action of ILP.
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CVT Inhibits the Intralipid Rescue of Bupivacaine-Induced Cardiotoxicity
in a Dose-Dependant Manner
Parisa Partownavid, Soban Umar, Siamak Rahman, Mansoureh Eghbali.
Intralipid (ILP) is effective in resuscitating Bupivacaine-induced cardiac arrest,
but it’s mechanism of action is not clear. Here we investigated whether protec-
tive action of ILP is mediated through fatty acid oxidation pathway using
CVT-4325, a fatty acid oxidation inhibitor. Male Sprague-Dawley rats (300-
350 g) were anesthetized (ketamine (80mg/kg) and xylazine (8mg/kg, i.p.))
and then ventilated. In control (CTRL, n=8), asystole was achieved with a single
dose of Bupivacaine (10mg/kg over 20 seconds, i.v.) and then resuscitation was
started immediately using ILP (5ml/kg bolus, and 0.5ml/kg/min maintenance)
together with cardiac massage. In CVT group (n=12), the protocol was identical
to CTRL, except that rats were pre-treated with different doses of CVT (0.5,
0.25, 0.125 and 0.0625mg/kg bolus i.v.) for 5 min. The heart rate (HR), ejection
fraction (EF) and fractional shortening (FS) were measured by echocardiogra-
phy. As expected, in CTRL group, administration of Bupivacaine resulted
in asystole and ILP improved HR and cardiac function gradually within
10 min; HR increased from 7353beats/min at 1 min to 180523beats/min
at 5min, and further to 243520beats/min at 10min. The left ventricular systolic
function fully recovered in all rats within 5min of ILP treatment (EF=7053%,
FS=4053%). In CVT pretreated group, however, there was no recovery of car-
diac function with ILP at CVT doses of 0.5, 0.25 and 0.125mg/kg within 10min
of ILP therapy. ILP was only able to rescue Bupivacaine-induced cardiotoxicity
at lowest dose of 0.0625 mg/kg CVT as cardiac function improved gradually
within 10min (HR from 65 at 1min to ~170min at 10 min; EF=~55%,
FS=~29% at 10min and QRS from 33 ms at 1 min to 27 ms at 10 min). In
conclusion CVT-4325 prevents intralipid rescue of Bupivacaine-induced cardi-
otoxicity in a dose dependant manner.
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Elasticity of Developing Cardiac Tissue and Influence on Early Cardio-
myocyte Beating
Stephanie F. Majkut, Dennis E. Discher.
Recent studies have demonstrated the effects of cardiomyocyte mechano-
sensitivity to ECM elasticity on beating physiology of 10 day chick embryocardiomyocytes[1] and also of neonatal rat cardiomyocytes[2], developmen-
tal stages for which the heart mechanics are established and the Young’s
modulus is E~10-20 kPa. Here we study the evolution of embryonic cardiac
tissue mechanics in parallel with the effects of microenvironment mechanics
on individual cardiomyocyte function throughout early development. To
measure the changing mechanical properties of cardiac tissue, we used mi-
cropipette aspiration to measure local and average bulk elastic moduli of
embryonic avian heart tissue. We observe stiffening of the looping heart
tube (days 2-4) from 1 kPa average elasticity to 2 kPa. We measure a greater
local elastic modulus in the inner curvature of the looping heart tube than
the outer curvature. Treating heart tubes with blebbistatin led to a uniform
30% decrease in elasticity, indicating that the local elasticity is not solely
due to actomyosin contractility. We performed a proteomic analysis of var-
ious anatomical positions along the 2-4 day heart tubes by mass spectrom-
etry, to measure the relative spaciotemporal changes in protein expression.
To explore the effects of the immediate microenvironment mechanics on
early cardiomyocyte function, heart cells were isolated from 2-4 day
chicken embryos, cultured on collagen-coated polyacrylamide gels of vary-
ing stiffness, and observed for effects of substrate elasticity on spontaneous
beating and morphology. After 24 hours in culture, cardiomyocyte beating
magnitude was larger on softer 1 kPa gels than on stiffer 5-34 kPa gels,
with no measurable difference in behavior with developmental stage.
[1] A. Engler et al. Journal of Cell Science 121: 3794-3802 (2008).
[2] J. Jacot, et al. Biophysical Journal 95(7): 3479-3487 (2008).
1606-Pos Board B516
Mechanisms of Prevention of Pulmonary Hypertension-Induced Right-
Ventricular Failure by Intralipid
Soban Umar, Rod Partow-Navid, Federica Maltese, Humann Matori,
Andrea Iorga, Parisa Partownavid, Mansoureh Eghbali.
Intralipid (ILP) has been used for treatment of local anesthetic-induced cardiac-
arrest and as source of parenteral nutrition. Some of its constituents are precur-
sors of pulmonary vasodilator prostaglandins. Pulmonary hypertension (PH) is
associated with pulmonary vascular remodeling leading to right-ventricular
(RV) hypertrophy and failure. Recently we found that ILP prevents PH in
rats. Here we investigated the mechanisms involved in this prevention. Rats
were treated with monocrotaline(60 mg/kg) to induce PH, and then either re-
ceived daily ILP (1 mL of 20% ILP/day) for 30days or left untreated to develop
RV failure (RVF). Saline treated rats served as control. Serial echocardiogra-
phy was performed to monitor cardiopulmonary hemodynamics., RV pressure
(RVP) was recorded by direct cardiac catheterization right before sacrifice.
Immunohistochemistry, confocal-microscopy, Western Blot analysis and RT-
PCR were performed. RVF group developed PH that led to RVF later with
significantly increased RVP (7055mmHg,n=10) and depressed RV ejection
fraction (RVEF=3452%). Severe structural changes in RV and lung were
observed in RVF group including RV-hypertrophy, increased lung weight, pul-
monary medial hypertrophy, fibrosis, apoptosis (upregulation of Caspase-3
(~10fold)), inflammation (increased expression of IL-6) and suppression of
angiogenesis (decreased VEGF and capillary-density). Furthermore, RVF
was associated with downregulation of phospho-eNOS(~4fold), Caveolin-1
(~6fold) adenosine-A2B receptor and estrogen receptor-b in lungs. In the
RV, adenosine-A2A receptor and estrogen receptor-b were downregulated in
RVF. ILP therapy prevented PH-induced RVF by restoring RVP
(3052mmHg,n=8) and RVEF(6351.5%) and attenuating RV hypertrophy
and lung remodeling. ILP suppressed inflammation and fibrosis along-with
improving angiogenesis and restoring phospho-eNOS, Caveolin-1 in lungs
and Caspase-3, adenosine-A2 and estrogen receptor-b expression in lungs
and RV. In conclusion ILP prevented PH and RV-failure by preserving cardio-
pulmonary structure and function and enhancing perfusion via adenosine
receptor, estrogen receptor-b and eNOS-mediated mechanisms.
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Sex Differences in the Mechanical Properties of Rat Myocardium After
Exposure to Simulated Microgravity
Mihail I. Mitov, Adam Tilley, Adhijit Patwardhan,
Esther E. Dupont-Versteegden, Kenneth S. Campbell.
Female astronauts are more likely than male astronauts to develop presyncope
and orthostatic intolerance when they return to normal gravity after space-
flights. The underlying mechanisms for this are unclear but could include
myocardial adaptations to micro-gravity conditions. This study was designed
to test whether there are sex-specific changes in the mechanical properties of
myocardial tissue in rats subjected to a period of simulated microgravity. Mul-
ticellular myocardial preparations were isolated from control male and female
Sprague-Dawley rats and corresponding experimental animals that were hind-
limb unloaded (HLU) for 14 days. Preparations were subjected to standard
mechanical tests imposed under muscle length control in solutions with pCa
